Equivalencies: 0 | Classes: 0 | Children: 0 | Explore

Entity

Name
oxygen radical
Namespace
chebi
Namespace Version
20180906
Namespace URL
https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns

Appears in Networks 1

Heme Curation v0.0.1-dev

Mechanistic knowledge surrounding heme

In-Edges 1

path(MESH:Sepsis) positiveCorrelation a(CHEBI:"oxygen radical") View Subject | View Object

Hemodynamics will be impaired, which on the one hand can lead to the production of oxygen radicals and thus directly to tissue damage. PubMed:29956069

Appears in Networks:
Annotations
MeSH
Arteries
MeSH
Sepsis
Text Location
Review

Out-Edges 2

a(CHEBI:"oxygen radical") positiveCorrelation path(MESH:Sepsis) View Subject | View Object

Hemodynamics will be impaired, which on the one hand can lead to the production of oxygen radicals and thus directly to tissue damage. PubMed:29956069

Appears in Networks:
Annotations
MeSH
Arteries
MeSH
Sepsis
Text Location
Review

a(CHEBI:"oxygen radical") directlyIncreases path(HP:"cell and tissue damage") View Subject | View Object

Hemodynamics will be impaired, which on the one hand can lead to the production of oxygen radicals and thus directly to tissue damage. PubMed:29956069

Appears in Networks:
Annotations
MeSH
Arteries
MeSH
Sepsis
Text Location
Review

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.